title: Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy.
abstract: Chronic puromycin aminonucleoside nephropathy (PAN) is an experimental analog of focal segmental glomerulosclerosis. Progressive renal damage in this model is partly mediated by excessive production of oxidant species. Whether dietary supplementation with vitamin E, an endogenous lipophilic antioxidant, ameliorates the severity of chronic PAN was tested. PAN was induced by seven serial injections of the glomerular epithelial cell toxin puromycin aminonucleoside, 2 mg/100 g body wt per dose, over a 12-wk period. Experimental animals (N = 8) received vitamin E-enriched chow (100 IU/kg), whereas control PAN rats (N = 10) were fed standard rodent diet containing vitamin E (30 IU/kg of chow). The administration of vitamin E had no effect on somatic growth or blood pressure; however, rats with PAN fed the vitamin E-enriched diet had an increased hematocrit. In addition, the experimental diet resulted in a 50% reduction in urinary total protein and albumin excretion and stabilization of the serum albumin, cholesterol, and triglyceride concentrations (P < 0.01). The inulin clearance was 69% higher in the vitamin E-supplemented animals (P < 0.001). Tubular function, namely, phosphate reabsorption and beta 2-microglobulin excretion, was improved in rats with chronic PAN treated with the vitamin E-enriched diet. There was a significant decrease in glomerulosclerosis and glomerular planar area, and tubulointerstitial scarring was diminished in vitamin E-treated animals with chronic PAN (P < 0.01). These beneficial effects on renal structure and function were associated with reduced malondialdehyde content in the kidney and liver.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Pediatrics, Schneider Children's Hospital, New Hyde Park, NY 11042, USA.
authors.forename: H
authors.initials: H
authors.lastname: Trachtman
authors.forename: N
authors.initials: N
authors.lastname: Schwob
authors.forename: J
authors.initials: J
authors.lastname: Maesaka
authors.forename: E
authors.initials: E
authors.lastname: Valderrama
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002908:Chronic Disease; D004032:Diet; D004305:Dose-Response Relationship, Drug; D005839:Gentamicins; D007668:Kidney / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology*; D007674:Kidney Diseases / Q000139:chemically induced* / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D011507:Proteinuria / Q000652:urine; D011692:Puromycin Aminonucleoside; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D014810:Vitamin E / Q000008:administration & dosage* / Q000494:pharmacology
chemical_list: D005839:Gentamicins; D014810:Vitamin E; D011692:Puromycin Aminonucleoside